000 01127 a2200349 4500
005 20250516231142.0
264 0 _c20150512
008 201505s 0 0 eng d
022 _a1365-2230
024 7 _a10.1111/ced.12408
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLynch, M
245 0 0 _aSitagliptin for severe psoriasis.
_h[electronic resource]
260 _bClinical and experimental dermatology
_cOct 2014
300 _a841-2 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAged
650 0 4 _aArthritis, Psoriatic
_xdrug therapy
650 0 4 _aDipeptidyl-Peptidase IV Inhibitors
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPyrazines
_xtherapeutic use
650 0 4 _aSitagliptin Phosphate
650 0 4 _aTreatment Outcome
650 0 4 _aTriazoles
_xtherapeutic use
700 1 _aTobin, A-M
700 1 _aAhern, T
700 1 _aO'Shea, D
700 1 _aKirby, B
773 0 _tClinical and experimental dermatology
_gvol. 39
_gno. 7
_gp. 841-2
856 4 0 _uhttps://doi.org/10.1111/ced.12408
_zAvailable from publisher's website
999 _c24127754
_d24127754